Trimethyl chitosan-cysteine-based nanoparticles as an effective delivery system for portulacerebroside A in the management of hepatocellular carcinoma cells <i>in vitro</i> and <i>in vivo</i>.
作者:
主题词
癌, 肝细胞(Carcinoma, Hepatocellular);动物(Animals);壳聚糖(Chitosan);肝肿瘤(Liver Neoplasms);人类(Humans);小鼠(Mice);纳米粒子(Nanoparticles);Toll样受体4(Toll-Like Receptor 4);小鼠, 裸(Mice, Nude);半胱氨酸(Cysteine);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);药物载体(Drug Carriers);药物释放系统(Drug Delivery Systems);男(雄)性(Male);细胞运动(Cell Movement);小鼠, 近交BALB C(Mice, Inbred BALB C)
DOI
10.1080/1061186X.2024.2344495
PMID
38625591
发布时间
2024-06-18
- 浏览0

Journal of drug targeting
570-584页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文